IMPACT OF CFTR MODULATOR THERAPY (LEXACAFTOR/TEZACAFTOR/IVACAFTOR) ON PSEUDOMONAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS

被引：0
|
作者：
Sheikh, Shahid I.
Britt, Rodney D.
Ryan-Wenger, Nancy A.
Khan, Aiman Q.
Gushue, Courtney A.
McCoy, Karen S.
Kopp, Benjamin
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1278
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1519A / 1520A
页数：2
相关论文
共 50 条
  • [1] Impact of elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy on rates of endoscopic sinus surgery in cystic fibrosis
    Pingree, Graham
    Bentan, Mihai
    Fitzpatrick, Thomas
    Schuman, Theodore
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (11) : 1692 - 1699
  • [2] IMPACT OF CFTR MODULATOR THERAPY (ELEACAFATOR/TEZACAFTOR/IVACAETOR) ON NILTHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND FUNGAL COLONIZATION AND INFLAMMATION IN CYSTIC FIBROSIS
    Sheikh, Shahid I.
    Britt, Rodney D.
    Ryan-Wenger, Nancy A.
    Khan, Aiman Q.
    Gushue, Courtney A.
    McCoy, Karen S.
    Kopp, Benjamin
    CHEST, 2022, 162 (04) : 354A - 355A
  • [3] Impact of elexacaftor/tezacaftor/ ivacaftor on respiratory colonization in an adult cystic fibrosis clinic
    Szabo, Michelle M.
    Foushee, Sarah E.
    Mcpheeters, Chelsey M.
    O'Hagan, Adrian R.
    Ramirez, Allan M.
    O'Reilly, Emily A.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 (05): : 337 - 342
  • [4] The CFTR modulator combination elexacaftor/tezacaftor/ivacaftor restores CFTR protein expression in circulating neutrophils of patients with cystic fibrosis
    Yusuf, Azeez
    Casey, Michelle
    Gogoi, Debananda
    Gabillard-Lefort, Claudie
    Gunaratnam, Cedric
    McElvaney, Noel G.
    Reeves, Emer P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S160 - S160
  • [5] Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis
    Sheikh, Shahid
    Britt, Rodney D. Jr Jr
    Ryan-Wenger, Nancy A.
    Khan, Aiman Q.
    Lewis, Brandon W.
    Gushue, Courtney
    Ozuna, Hazel
    Jaganathan, Devi
    McCoy, Karen
    Kopp, Benjamin T.
    PEDIATRIC PULMONOLOGY, 2023, 58 (03) : 825 - 833
  • [6] THE INFLUENCE OF THE CFTR MODULATOR IVACAFTOR ON ASPERGILLOSIS IN CYSTIC FIBROSIS
    Fritsch, N. C.
    Green, H. D.
    Jones, A. M.
    Barry, P. J.
    THORAX, 2019, 74 : A11 - A12
  • [7] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [8] Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
    Bacalhau, Mafalda
    Camargo, Mariana
    Magalhaes-Ghiotto, Grace A. V.
    Drumond, Sybelle
    Castelletti, Carlos Henrique M.
    Lopes-Pacheco, Miqueias
    PHARMACEUTICALS, 2023, 16 (03)
  • [9] Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study
    Giron, Rosa Ma
    Carrasco-Hernandez, Laura
    Pelaez, Adrian
    Bonilla, Ainhoa Gomez
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (03): : 193 - 195
  • [10] Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome
    Pallenberg, Sophia T.
    Pust, Marie-Madlen
    Rosenboom, Ilona
    Hansen, Gesine
    Wiehlmann, Lutz
    Dittrich, Anna-Maria
    Tummler, Burkhard
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
12345